These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 656285)

  • 1. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
    Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
    Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
    Wells PG; Feely J; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
    Zeeh J; Lange H; Bosch J; Pohl S; Loesgen H; Eggers R; Navasa M; Chesta J; Bircher J
    Gastroenterology; 1988 Sep; 95(3):749-59. PubMed ID: 3396820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: measurement of alfentanil hepatic extraction coefficient.
    Chauvin M; Bonnet F; Montembault C; Levron JC; Viars P
    Anesth Analg; 1986 Oct; 65(10):999-1003. PubMed ID: 2875679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Anttila M; Sundqvist H
    Br J Clin Pharmacol; 1980 Apr; 9(4):399-405. PubMed ID: 7378257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the route of administration on the mean hepatic extraction ratio of propranolol in the rat.
    Suzuki T; Isozaki S; Ohkuma T; Rikihisa T
    J Pharmacobiodyn; 1980 Nov; 3(11):603-11. PubMed ID: 7241334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of posture on hepatic perfusion and the presystemic biotransformation of propranolol: simulation of the food effect.
    Modi MW; Hassett JM; Lalka D
    Clin Pharmacol Ther; 1988 Sep; 44(3):268-74. PubMed ID: 3046813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on the hepatic clearance of propranolol in rats.
    Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
    J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.
    Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.